Four pharmaceuticals to pay $124 million for submission of false claims to Medicaid
Compliance Monitor, October 21, 2009
Want to receive articles like this one in your inbox? Subscribe to Compliance Monitor!
AstraZeneca, Mylan Pharmaceuticals, Ortho McNeil Pharmaceutical, and UDL Laboratories, have agreed to pay settlements totaling $124 million to resolve claims that the companies failed to appropriately reimburse state Medicaid programs for drug purchases, according to a Department of Justice (DOJ) press release.
The four companies failed to comply with The Medicaid Prescription Drug Rebate Program, which states that companies must pay rebates to Medicaid on the basis of whether a drug is an “innovator” drug or a “non-innovator” drug. An innovator drug’s price is much higher than the rebate for non-innovator drugs.
According to the DOJ, each company paid a settlement resolving allegations that it had sold innovator drugs manufactured by other companies, and classified those drugs as non-innovator drugs for Medicaid rebate purposes. Through the improper classification of these drugs, the companies underpaid their rebate obligations to the Medicaid Rebate Program.
The whistleblower, Ven-A-Care Corporation, will receive over $10.7 million as its share of the recovery.
Want to receive articles like this one in your inbox? Subscribe to Compliance Monitor!
Related Products
-
Strategies for Health Care Compliance
News and real-life examples to increase the effectiveness of your compliance program. Strategies for Health Care Compliance...
-
Compliance Monitor
This HTML e-mail newsletter delivers news on Medicare and Medicaid fraud and abuse, as well as recent documents and targets...
-
Medicare Weekly Update
Each issue of Medicare Weekly Update includes the latest CMS proposed and final rules, CMS manual revisions, and...
-
Medicare Update for Physician Services
Medicare Update for Physician Services is a free, monthly e-zine that delivers news and information to help physician...
Most Popular
- Articles
-
- HIPAA Q&A: Flu shot requirement for hospital employees
- HealthDataInsights posts new issues for medical necessity claims
- Running an effective peer review committee meeting
- Q&A: Incidental disclosures and patient privacy
- New FAQ posted on storing laryngoscope blades
- Sneak Peek: Effort underway to establish caseload benchmarks
- Tip: Perform your own internal investigation prior to government audit
- What does case-mix index mean to you?
- HIPAA 5010 deadline extended, but threat remains, says AMA
- HHS task force: Consider privacy, security with text messages
- E-mailed
-
- Running an effective peer review committee meeting
- HIPAA Q&A: Flu shot requirement for hospital employees
- What does case-mix index mean to you?
- HHS task force: Consider privacy, security with text messages
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Tip: Correctly code bilateral pain management procedures
- 2012 CPT code changes for ASCs: Shoulder and knee scopes and pain management
- COT basics to best
- Documentation and coding for toxic metabolic encephalopathy
- Guidance and tact key to compliant, effective physician queries
- Searched